about
Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination.A new strategy based on SmRho protein loaded chitosan nanoparticles as a candidate oral vaccine against schistosomiasisMucosal vaccines: recent progress in understanding the natural barriers.Progress towards a needle-free hepatitis B vaccine.Immune response elicited by an intranasally delivered HBsAg low-dose adsorbed to poly-ε-caprolactone based nanoparticles.Intranasal Administration of Novel Chitosan Nanoparticle/DNA Complexes Induces Antibody Response to Hepatitis B Surface Antigen in Mice.Validation of a new 96-well plate spectrophotometric method for the quantification of compound 48/80 associated with particles.Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.Preparation of coated nanoparticles for a new mucosal vaccine delivery system.Adjuvant Activity of Poly-ε-caprolactone/Chitosan Nanoparticles Characterized by Mast Cell Activation and IFN-γ and IL-17 Production.Effect of particulate adjuvant on the anthrax protective antigen dose required for effective nasal vaccination.Development of a novel adjuvanted nasal vaccine: C48/80 associated with chitosan nanoparticles as a path to enhance mucosal immunity.Poly-ε-caprolactone/Chitosan and Chitosan Particles: Two Recombinant Antigen Delivery Systems for Intranasal Vaccination.Oral vaccination based on DNA-chitosan nanoparticles against Schistosoma mansoni infectionInteractions between copper(II) dibrominated salen complex and copolymeric micelles of P-123 and F-127Polymeric nanoengineered HBsAg DNA vaccine designed in combination with β‑glucanImmune response by nasal delivery of hepatitis B surface antigen and codelivery of a CpG ODN in alginate coated chitosan nanoparticlesEvaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticlesInduction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymersChitosan:β-glucan particles as a new adjuvant for the hepatitis B antigenExosomes as adjuvants for the recombinant hepatitis B antigen: First reportChitosan-Based Nanoparticles as a Hepatitis B Antigen Delivery SystemEasy and effective method to generate endotoxin-free chitosan particles for immunotoxicology and immunopharmacology studiesEarly Interaction of Alternaria infectoria Conidia with MacrophagesGlucan Particles Are a Powerful Adjuvant for the HBsAg, Favoring Antiviral Immunity
P50
Q33253729-A1CF34B1-275A-442C-B8A3-545522016986Q34500826-9E33D4BF-F612-4B7D-919B-16F43254235CQ37642613-F3F757AE-78E3-4E2B-BEF8-ACBBF35DA288Q37810816-63528028-5D85-4773-9D9A-C81251E4FAE3Q38786375-4A10DDC4-8B6E-436F-A6C2-543EA0D0625FQ41063700-730233B4-FD25-4176-B111-6944F5937543Q41123478-5B95050E-20D7-49D8-8BC3-25B9983EB789Q46359639-10192216-92E3-4E5C-AD7F-E08677AF4121Q46584817-25CDA181-520E-4B03-9D63-D0389A15B97BQ48263999-1714122A-E736-4C0C-9C79-695D1B6FA879Q50962149-F1EDA13A-9CD9-4C6F-909D-0ED0482465FEQ50995133-5AE02CB6-0ED4-48A9-98A4-1CA79036A256Q53123215-20544BCC-325B-43F0-A460-A7AF5AB0E242Q57556377-63A57DC6-252A-4583-873D-E277931567D0Q57672003-0158556F-E185-4E96-BAD1-12B9C08487C1Q58607080-30E9FD0B-69F5-4494-8B79-1B89CDCF4050Q58854005-1A5F92F5-A3A2-4C16-802F-DBE5AE6E95D7Q58854014-34C8326A-8ABC-41ED-9686-98B6EF602C41Q58854016-C285D22A-8546-427F-9DC5-E4B7BFA71DC1Q60619676-315DB8E4-45F2-4821-A468-A865275D8C01Q60619678-17198E94-C66C-4F14-8DB0-82F37A261215Q60619693-A61B3329-36E0-41DE-9A74-7639537F6F44Q91918847-B9B95223-5F2E-48CF-AED6-84D88B02B613Q92649260-79058A54-CB74-4C07-AFCD-F5AC464C6A7DQ92968668-C5274869-32B5-4FF2-82D0-B3C6F6A47F78
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Olga Borges
@ast
Olga Borges
@en
Olga Borges
@es
Olga Borges
@nl
Olga Borges
@sl
type
label
Olga Borges
@ast
Olga Borges
@en
Olga Borges
@es
Olga Borges
@nl
Olga Borges
@sl
altLabel
Olga Borges Ribeiro
@en
prefLabel
Olga Borges
@ast
Olga Borges
@en
Olga Borges
@es
Olga Borges
@nl
Olga Borges
@sl
P106
P1153
8529429500
P21
P214
3215155044774772520000
P31
P3835
olga-borges2
P496
0000-0002-2215-5121
P734
P735
P7859
viaf-3215155044774772520000